Source: Virtual Congress 2021 – COVID - 19: lessons learned



Rating:

Share or cite this content

Citations should be made in the following way:
S. Chakroun (Tunis, Tunisia), S. Mokaddem (Tunis, Tunisia), A. Chaker (Tunis, Tunisia), K. Kchaou (Tunis, Tunisia), S. Jameleddine (Tunis, Tunisia). Usefulness of the ILD-GAP index in predicting COVID-19 pneumonia prognosis. 512

Member's Comments

No comment yet.

Related content which might interest you: Usefulness of shock index in severity assessment of community-acquired pneumonia Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections Year: 2007 Usefulness of shock index predictive value in mortality assessment in community acquired pneumonia Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013 Determining the best diagnostic biomarker for sepsis and prognosis assessment Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Biomarkers for the prognostic assessment and disease severity evaluation in community-acquired pneumonia (CAP) Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Admission lactate predicts poor prognosis independently of the CRB/CURB-65 scores in community-acquired pneumonia. Source: International Congress 2017 – Update on community acquired pneumonia Year: 2017 Validation of indices and predictive rules of severity for community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 560s Year: 2002 Criteria for predicting the course and outcome of pneumonia Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Prognostic usefulness of severity scales for the initial assessment of elderly people with a diagnosis of pneumonia due to COVID-19. Design of a multivariate predictive model of mortality. Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 Performance of the CORB score for predicting clinical outcomes in community-acquired pneumonia. Source: Virtual Congress 2021 – Pneumonia Year: 2021 Prognostic evaluation of COPD patients with pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 257s Year: 2005 Value of bacteraemia as an unfavourable prognostic factor for community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 350s Year: 2006 Predictive value of multiorgan imaging biomarkers for predicting exacerbations in COPD patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Usefulness of CURB-65, PSI and MuLBSTA in predicting COVID-19 mortality Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 Importance of admission biomarkers in prognostication of  patients with SARS-Cov-2 Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure Year: 2021 Usefulness of procalcitonin as a predictor for bacteremia and prognosis in severe sepsis Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism Year: 2016 Role of chest ultrasonography in prognosis of community-acquired pneumonia Source: International Congress 2016 – A view into a chest and pleural pathology Year: 2016 Comparison of biomarkers and SOFA score prognostic value in ventilator-associated pneumonia Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009 Correlation of procalcitonin and CRP in community-acquired pneumonia with CRB-65 score and prognosis – results from the German competence network CAPNETZ Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 The role of procalcitonin in predicting severity and clinical course of aspiration pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Procalcitonin and D-dimer to predict prognosis and clinical outcomes in severe community-acquired pneumonia (SCAP) patients Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012